Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 72,582 shares at $7.19 ($522K) on 2025-03-13, disclosed to the SEC on 2025-03-17.
Open-market sale of $522k ADPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.19 | 36,291 | $261K | 50.0% |
| 2 | $7.19 | 36,291 | $261K | 50.0% |
| Total | $7.19 avg | 72,582 | $522K | 100% |
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |
| ADPT | SELL | 2023-03-29 | $20K | — | Filing → |